Noninvasive screening management method and system for hyperlipemia people based on dynamic spectrometry

The non-invasive screening and management system for hyperlipidemia using dynamic spectroscopy solves the problem of non-invasive screening for hyperlipidemia by utilizing facial video capture and spectral analysis, achieving efficient and accurate screening and remote management.

CN118924295APending Publication Date: 2024-11-12吾征智能技术(北京)有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411130473.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Existing technologies cannot achieve non-invasive, non-contact large-scale screening of people with hyperlipidemia, resulting in low testing efficiency, large workload, and high demand for human and material resources.

Method used

A non-invasive screening and management system for hyperlipidemia based on dynamic spectroscopy is adopted. By collecting facial videos, the system uses a near-infrared dynamic spectroscopy acquisition device to obtain spectral information of blood components. Combined with Monte Carlo and chemometric algorithms, data on cholesterol, triglycerides, and low-density lipoprotein are extracted, and detection thresholds are set for screening.

Benefits of technology

It enables non-invasive, large-scale, and rapid non-contact testing for people with hyperlipidemia, reducing personnel requirements, improving the efficiency and accuracy of screening and testing, and supporting remote data monitoring and collaborative diagnosis and treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924295A_ABST
    Figure CN118924295A_ABST
Patent Text Reader

Abstract

The embodiment of the invention discloses a hyperlipemia crowd noninvasive screening management method and system based on a dynamic spectrum method, and the method comprises the steps: collecting a certain number of face videos, carrying out the preprocessing of the face videos, and obtaining the preprocessing data; obtaining index information data corresponding to the preprocessed data through a dynamic spectrum technology; wherein the index information data comprises cholesterol data, triglyceride data and low and high density lipoprotein data; setting a detection threshold value, judging whether all the index information data exceed the detection threshold value, and if all the index information data exceed the detection threshold value, judging that the crowd belongs to the hyperlipemia crowd; if all the index information data do not exceed the detection threshold value, determining that the people do not belong to the hyperlipemia population; and if the index information data exceeds one of the detection threshold values, determining that the object is a hyperlipidemia key monitoring object. The problem that in the prior art, people suffering from hyperlipemia cannot be noninvasively screened and managed is solved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of artificial intelligence technology, and in particular to a non-invasive screening management system, method, electronic equipment and storage medium for hyperlipidemia population based on dynamic spectroscopy. Background Art

[0002] Hyperlipidemia refers to the abnormal metabolism or operation of fat, which causes the blood lipid content in the human body to exceed the normal range, manifested as high cholesterol and (or) triglycerides or low high-density lipoprotein in the blood. Modern medicine calls it "dyslipidemia". Hyperlipidemia is a common and frequently occurring disease, and is the culprit of cardiovascular and cerebrovascular diseases. The damage to the body is hidden, gradual, progressive and systemic. Its direct damage is to accelerate systemic atherosclerosis.

[0003] Traditional hyperlipidemia detection and screening are mainly achieved through blood tests and other methods. This process is complicated and inefficient, and cannot achieve non-invasive, non-contact large-scale screening. Especially when multiple communities are involved, this method is labor-intensive, slow, and inefficient, and requires a lot of manpower and material resources to support it.

[0004] Therefore, there is an urgent need for a simple, sensitive, accurate, non-contact, non-invasive detection method to relieve patients' pain, increase the frequency of detection, and thus conduct screening and management of people with hyperlipidemia. Summary of the invention

[0005] The purpose of the embodiments of the present invention is to provide a non-invasive screening management system, method, electronic device and storage medium for hyperlipidemia population based on dynamic spectroscopy, so as to solve the problem that non-invasive screening and management of hyperlipidemia population cannot be achieved in the prior art.

[0006] To achieve the above objectives, the present invention provides a non-invasive screening and management method for hyperlipidemia population based on dynamic spectroscopy, the method specifically comprising:

[0007] Collecting a certain number of human face videos, preprocessing the human face videos to obtain preprocessed data;

[0008] Obtaining the index information data corresponding to the pre-processed data by dynamic spectroscopy technology; wherein the index information data includes cholesterol data, triglyceride data and low high-density lipoprotein data;

[0009] Setting a detection threshold to determine whether all the indicator information data exceed the detection threshold. If all the indicator information data exceed the detection threshold, the patient is determined to be a hyperlipidemia patient.

[0010] If all the indicator information data do not exceed the detection threshold, it is determined that the person does not belong to the hyperlipidemia population;

[0011] If the indicator information data exceeds one of the detection thresholds, the individual is determined to be a key monitoring target for hyperlipidemia.

[0012] On the basis of the above technical solution, the present invention can also be improved as follows:

[0013] Furthermore, the collecting of a certain number of human face videos and preprocessing of the human face videos to obtain preprocessed data includes:

[0014] The facial video of the human face is collected by a near-infrared dynamic spectrum acquisition device to obtain the spectrum information of the blood components under the skin of the human face;

[0015] The wave number band information is obtained by screening the wave number band combination with obvious correlation with the components of the compound to be tested in the spectral information through interval partial least squares;

[0016] The wave number segment information is extracted into wave number point information in combination with the Monte Carlo algorithm.

[0017] Furthermore, the indicator information data corresponding to the pre-processed data is obtained by dynamic spectroscopy technology, including:

[0018] Extracting a plurality of original features based on the preprocessed data;

[0019] Calculate the correlation coefficients of the original features corresponding to the hyperlipidemia population;

[0020] The original features whose correlation coefficients exceed the preset standard range are extracted as indicator information data.

[0021] Furthermore, the detection threshold of the cholesterol data is 572mmol / L;

[0022] The detection threshold of the triglyceride data is 1.70mmol / L;

[0023] The detection threshold of the low high-density lipoprotein data is 9.0 mmol / L.

[0024] Furthermore, the non-invasive screening management of hyperlipidemia population based on dynamic spectroscopy also includes:

[0025] When the cholesterol data exceeds 572mmol / L and the triglyceride data is <1.70mmol / L, it is judged as hypercholesterolemia;

[0026] When the triglyceride data exceeds 1.70mmol / L and the cholesterol data is <572mmol / L, it is judged as hypertriglyceridemia

[0027] When the cholesterol data exceeds 572mmol / L and the triglyceride data exceeds 1.70mmol / L, it is judged as mixed hyperlipidemia;

[0028] When the low high-density lipoprotein data is less than 9.0mmol / L, it is judged as low high-density lipoproteinemia.

[0029] Furthermore, the non-invasive screening management of hyperlipidemia population based on dynamic spectroscopy also includes:

[0030] A corresponding treatment plan is determined based on the type of hyperlipidemia, and the treatment plan is sent to a corresponding treatment personnel user terminal.

[0031] Furthermore, the non-invasive screening management of hyperlipidemia population based on dynamic spectroscopy also includes:

[0032] Assign a unique identification code to each screening area;

[0033] The location of the community hyperlipidemia screening area corresponding to the key hyperlipidemia monitoring object is obtained through the unique identification code.

[0034] A non-invasive screening and management system for hyperlipidemia population based on dynamic spectroscopy, comprising:

[0035] A collection module is used to collect a certain number of facial videos;

[0036] A preprocessing module, used for preprocessing the face video to obtain preprocessed data;

[0037] An index extraction module, used for obtaining index information data corresponding to the pre-processed data through dynamic spectroscopy technology; wherein the index information data includes cholesterol data, triglyceride data and low high-density lipoprotein data;

[0038] A judgment module is used to set a detection threshold to judge whether all the indicator information data exceed the detection threshold. If all the indicator information data exceed the detection threshold, it is judged that the patient belongs to the hyperlipidemia population;

[0039] If all the indicator information data do not exceed the detection threshold, it is determined that the person does not belong to the hyperlipidemia population;

[0040] If the indicator information data exceeds one of the detection thresholds, the patient is determined to be a hyperlipidemia patient to be observed.

[0041] An electronic device comprises a memory, a processor and a computer program stored in the memory and executable on the processor, wherein the steps of the method are implemented when the processor executes the computer program.

[0042] A non-transitory computer-readable storage medium stores a computer program, which implements the steps of the method when executed by a processor.

[0043] The embodiments of the present invention have the following advantages:

[0044] The non-invasive screening and management method for hyperlipidemia population based on dynamic spectroscopy in the present invention can realize non-invasive, large-scale non-contact rapid detection, screening and collaborative diagnosis and treatment, and remote data monitoring of community hyperlipidemia population, without the need for personnel on duty, reducing the demand for personnel and improving the performance of remote screening and detection services. It solves the problem that the existing technology cannot perform non-invasive screening and management of hyperlipidemia population. BRIEF DESCRIPTION OF THE DRAWINGS

[0045] In order to more clearly illustrate the implementation methods of the present invention or the technical solutions in the prior art, the following briefly introduces the drawings required for the implementation methods or the description of the prior art. Obviously, the drawings in the following description are only exemplary, and for ordinary technicians in this field, other implementation drawings can be derived from the provided drawings without creative work.

[0046] The structures, proportions, sizes, etc. illustrated in this specification are only used to match the contents disclosed in the specification so as to facilitate understanding and reading by persons familiar with the technology. They are not used to limit the conditions under which the present invention can be implemented, and therefore have no substantial technical significance. Any structural modification, change in proportion or adjustment of size shall still fall within the scope of the technical contents disclosed in the present invention without affecting the effects and purposes that can be achieved by the present invention.

[0047] Figure 1 This is a flow chart of the non-invasive screening and management method for hyperlipidemia population based on dynamic spectroscopy of the present invention;

[0048] Figure 2 This is a first architecture diagram of the non-invasive screening management system for hyperlipidemia population based on dynamic spectroscopy of the present invention;

[0049] Figure 3 This is a second architecture diagram of the non-invasive screening management system for hyperlipidemia population based on dynamic spectroscopy of the present invention;

[0050] Figure 4 This is a schematic diagram of the physical structure of the electronic device provided by the present invention.

[0051] The accompanying drawings are denoted as follows:

[0052] Collection module 10 , preprocessing module 20 , indicator extraction module 30 , judgment module 40 , management module 50 , electronic device 60 , processor 601 , memory 602 , bus 603 . DETAILED DESCRIPTION

[0053] The following is a description of the implementation of the present invention by specific embodiments. People familiar with the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0054] Figure 1 FIG. 1 is a flow chart of an embodiment of a non-invasive screening management method for hyperlipidemia population based on dynamic spectroscopy of the present invention, as shown in FIG. Figure 1 As shown, a non-invasive screening and management method for hyperlipidemia population based on dynamic spectroscopy provided by an embodiment of the present invention comprises the following steps:

[0055] S101, collecting a certain number of human face videos, preprocessing the human face videos, and obtaining preprocessed data;

[0056] Specifically: a facial video of a human face is collected by a near-infrared dynamic spectrum collection device to obtain spectral information of blood components under the skin of the human face;

[0057] Based on the collected facial videos, the spectrum of the pulsating arterial blood components under the skin of the community population is obtained, which is the original data of the blood components; after pre-selecting the spectral sample data of the blood components of the above-collected population using the effective wavelength number, the spectral samples of the blood components of the above-collected population are preprocessed (including using software algorithms such as Boxcar filter, wavelet transform filter and empirical mode decomposition filter to preprocess the original spectral data and the spectral sample data of the blood components of the above-collected population, respectively), to obtain the preprocessed blood component spectrum of the above-mentioned population, use the chemometric algorithm to establish a functional relationship between the spectrum of the above-mentioned sample and the content of its components, and establish a discrimination model between hyperlipidemia-related values ​​and dynamic spectra.

[0058] The wave number band information is obtained by screening the wave number band combination with obvious correlation with the components of the compound to be tested in the spectral information through interval partial least squares;

[0059] The wave number segment information is extracted into wave number point information in combination with the Monte Carlo algorithm.

[0060] S102, obtaining index information data corresponding to the preprocessed data through dynamic spectroscopy technology;

[0061] Specifically, extracting a number of original features based on the preprocessed data;

[0062] Calculate the correlation coefficients of the original features corresponding to the hyperlipidemia population;

[0063] The original features whose correlation coefficients exceed the preset standard range values ​​are extracted as indicator information data; the indicator information data includes cholesterol data, triglyceride data and low high-density lipoprotein data.

[0064] S103, setting a detection threshold, determining whether all the indicator information data exceed the detection threshold, if all the indicator information data exceed the detection threshold, determining that the patient belongs to the hyperlipidemia population;

[0065] Specifically, basic file information and data of multiple hyperlipidemia populations are obtained, and preliminary classification objects are determined based on the set basic screening range of hyperlipidemia populations. Generally speaking, according to the test results, hyperlipidemia classification includes: hypercholesterolemia, hypertriglyceridemia, combined hyperlipidemia, low high-density lipoproteinemia, etc.

[0066] The detection threshold of the cholesterol data is 572 mmol / L;

[0067] The detection threshold of the triglyceride data is 1.70 mmol / L;

[0068] The detection threshold of the low high-density lipoprotein data is 9.0 mmol / L.

[0069] When the cholesterol data exceeds 572 mmol / L and the triglyceride data is less than 1.70 mmol / L, it is judged as hypercholesterolemia;

[0070] When the triglyceride data exceeds 1.70mmo l / L and the cholesterol data is <572mmo l / L, it is considered hypertriglyceridemia.

[0071] When the cholesterol data exceeds 572 mmol / L and the triglyceride data exceeds 1.70 mmol / L, it is judged as mixed hyperlipidemia;

[0072] When the low high-density lipoprotein data is less than 9.0 mmol / L, it is diagnosed as low high-density lipoproteinemia.

[0073] S104, if all the indicator information data do not exceed the detection threshold, it is determined that the person does not belong to the hyperlipidemia population;

[0074] S105, if the indicator information data exceeds one of the detection thresholds, the subject is determined to be a key monitoring subject for hyperlipidemia;

[0075] The non-invasive screening management method for hyperlipidemia population based on dynamic spectroscopy also includes:

[0076] The corresponding treatment plan is determined based on the type of hyperlipidemia, and the treatment plan is sent to the corresponding treatment personnel user terminal. For example, the key monitoring subjects of hyperlipidemia are followed up at least 4 times a year.

[0077] Assign a unique identification code to each screening area;

[0078] The location of the community hyperlipidemia screening area corresponding to the key hyperlipidemia monitoring object is obtained through the unique identification code.

[0079] The non-invasive screening and management method for hyperlipidemia population based on dynamic spectroscopy collects a certain number of human face videos, pre-processes the human face videos, and obtains pre-processed data; obtains index information data corresponding to the pre-processed data through dynamic spectroscopy technology; wherein the index information data includes cholesterol data, triglyceride data, and low high-density lipoprotein data; sets a detection threshold to determine whether all the index information data exceed the detection threshold, if all the index information data exceed the detection threshold, it is determined to belong to the hyperlipidemia population; if all the index information data do not exceed the detection threshold, it is determined not to belong to the hyperlipidemia population; if the index information data exceeds one of the detection thresholds, it is determined to be a key monitoring target for hyperlipidemia. The problem that the existing technology cannot perform non-invasive screening and management of hyperlipidemia population is solved.

[0080] Figure 2-Figure 3 FIG. 1 is a flow chart of an embodiment of a non-invasive screening management system for hyperlipidemia population based on dynamic spectroscopy of the present invention; Figure 2-Figure 3 As shown, an embodiment of the present invention provides a non-invasive screening and management system for hyperlipidemia population based on dynamic spectroscopy, comprising the following steps:

[0081] The acquisition module 10 is used to acquire a certain number of facial videos;

[0082] A preprocessing module 20, used for preprocessing the face video to obtain preprocessed data;

[0083] The pre-processing module 20 is also used for:

[0084] The facial video of the human face is collected by a near-infrared dynamic spectrum acquisition device to obtain the spectrum information of the blood components under the skin of the human face;

[0085] The wave number band information is obtained by screening the wave number band combination with obvious correlation with the components of the compound to be tested in the spectral information through interval partial least squares;

[0086] The wave number segment information is extracted into wave number point information in combination with the Monte Carlo algorithm.

[0087] The index extraction module 30 is used to obtain the index information data corresponding to the pre-processed data through dynamic spectroscopy technology; wherein the index information data includes cholesterol data, triglyceride data and low high-density lipoprotein data;

[0088] The indicator extraction module 30 is also used for:

[0089] Extracting a plurality of original features based on the preprocessed data;

[0090] Calculate the correlation coefficients of the original features corresponding to the hyperlipidemia population;

[0091] The original features whose correlation coefficients exceed the preset standard range are extracted as indicator information data.

[0092] A judgment module 40 is used to set a detection threshold and judge whether all the indicator information data exceeds the detection threshold;

[0093] The detection threshold of the cholesterol data is 572 mmol / L;

[0094] The detection threshold of the triglyceride data is 1.70 mmol / L;

[0095] The detection threshold of the low high-density lipoprotein data is 9.0 mmol / L.

[0096] When the cholesterol data exceeds 572 mmol / L and the triglyceride data is less than 1.70 mmol / L, it is judged as hypercholesterolemia;

[0097] When the triglyceride data exceeds 1.70mmo l / L and the cholesterol data is <572mmo l / L, it is judged as hypertriglyceridemia

[0098] When the cholesterol data exceeds 572 mmol / L and the triglyceride data exceeds 1.70 mmol / L, it is judged as mixed hyperlipidemia;

[0099] When the low high-density lipoprotein data is less than 9.0 mmol / L, it is diagnosed as low high-density lipoproteinemia.

[0100] If all the indicator information data exceed the detection threshold, it is determined that the patient belongs to the hyperlipidemia population;

[0101] If all the indicator information data do not exceed the detection threshold, it is determined that the person does not belong to the hyperlipidemia population;

[0102] If the index information data exceeds one of the detection thresholds, the patient is determined to be a hyperlipidemia patient to be observed;

[0103] The management module 50 is used to determine a corresponding treatment plan based on the type of hyperlipidemia, and send the treatment plan to the corresponding treatment personnel user terminal.

[0104] Assign a unique identification code to each screening area;

[0105] The location of the community hyperlipidemia screening area corresponding to the key hyperlipidemia monitoring object is obtained through the unique identification code.

[0106] The remote management platform makes statistics, analysis and evaluation on the hyperlipidemia population screening areas corresponding to the screening records, notification records, collaborative diagnosis and treatment records, health management records, population file information and the unique identification code of the key hyperlipidemia monitoring subjects.

[0107] The edge processing terminal provides a faster response speed to the above computing service needs, and usually does not need to send a large amount of raw data back to the core network or the cloud.

[0108] The edge processing terminal is used to generate secondary analysis address information based on facial video information; when the secondary analysis address is local, the facial video terminal performs secondary analysis on the collected information and makes corresponding operations based on the analysis results; when the secondary analysis address is remote, the edge processing terminal transmits the secondary analysis address information and the collected information to the cloud management and control terminal.

[0109] The present invention discloses a non-invasive screening management system for hyperlipidemia population based on dynamic spectroscopy, wherein a certain number of human face videos are collected by a collection module 10; the human face videos are pre-processed by a pre-processing module 20 to obtain pre-processed data; the index information data corresponding to the pre-processed data is obtained by dynamic spectroscopy technology; wherein the index information data includes cholesterol data, triglyceride data and low high-density lipoprotein data; a detection threshold is set to determine whether the index information data all exceed the detection threshold, if the index information data all exceed the detection threshold, it is determined to belong to the hyperlipidemia population; if the index information data all do not exceed the detection threshold, it is determined not to belong to the hyperlipidemia population; if the index information data exceeds one of the detection thresholds, it is determined to belong to the hyperlipidemia patient to be observed. The non-invasive screening management method for hyperlipidemia population based on dynamic spectroscopy solves the problem that the prior art cannot perform non-invasive screening and management of hyperlipidemia population.

[0110] The non-invasive screening and management system for hyperlipidemia population based on dynamic spectroscopy of the present invention requires one or more near-infrared dynamic spectral acquisition devices with both spectral and imaging functions and a remote management platform as well as a hyperlipidemia community collaborative diagnosis and treatment and health management system. By acquiring facial videos of community people and utilizing dynamic spectroscopy technology, non-invasive rapid detection, screening and intelligent health management services for large-scale community hyperlipidemia populations can be completed. For key monitoring objects, collaborative diagnosis and treatment and continuous health management are carried out according to the integrated care plan for hyperlipidemia patients. The physical sign data of hyperlipidemia screening objects, key monitoring objects and detection are received, as well as collaborative diagnosis and treatment and health management records are recorded, and tracking and statistical services are provided.

[0111] Figure 4 A schematic diagram of the physical structure of an electronic device provided in an embodiment of the present invention, such as Figure 4 As shown, the electronic device 60 includes: a processor 601 (processor), a memory 602 (memory) and a bus 603;

[0112] The processor 601 and the memory 602 communicate with each other via the bus 603;

[0113] The processor 601 is used to call the program instructions in the memory 602 to execute the methods provided by the above-mentioned method embodiments, for example, including: collecting a certain number of human face videos, preprocessing the human face videos, and obtaining preprocessed data; obtaining indicator information data corresponding to the preprocessed data through dynamic spectroscopy technology; wherein the indicator information data includes cholesterol data, triglyceride data, and low high-density lipoprotein data; setting a detection threshold to determine whether the indicator information data all exceed the detection threshold, if the indicator information data all exceed the detection threshold, it is determined that the person belongs to the hyperlipidemia population; if the indicator information data all do not exceed the detection threshold, it is determined that the person does not belong to the hyperlipidemia population; if the indicator information data exceeds one of the detection thresholds, it is determined that the person is a key monitoring target for hyperlipidemia.

[0114] The present embodiment provides a non-transitory computer-readable storage medium, which stores computer instructions. The computer instructions enable a computer to execute the methods provided by the above-mentioned method embodiments, for example, including: collecting a certain number of human face videos, preprocessing the human face videos, and obtaining preprocessed data; obtaining indicator information data corresponding to the preprocessed data through dynamic spectroscopy technology; wherein the indicator information data includes cholesterol data, triglyceride data, and low-density lipoprotein data; setting a detection threshold to determine whether all the indicator information data exceed the detection threshold, if all the indicator information data exceed the detection threshold, it is determined that the person belongs to the hyperlipidemia population; if all the indicator information data do not exceed the detection threshold, it is determined that the person does not belong to the hyperlipidemia population; if the indicator information data exceeds one of the detection thresholds, it is determined that the person is a key monitoring target for hyperlipidemia.

[0115] A person skilled in the art can understand that all or part of the steps of implementing the above method embodiment can be completed by hardware related to program instructions, and the aforementioned program can be stored in a computer-readable storage medium. When the program is executed, it executes the steps of the above method embodiment; and the aforementioned storage medium includes: ROM, RAM, magnetic disk or optical disk, etc., various storage media that can store program codes.

[0116] The device embodiments described above are merely illustrative, wherein the units described as separate components may or may not be physically separated, and the components shown as units may or may not be physical units, i.e., they may be located in one place, or they may be distributed on multiple network units. Some or all of the modules may be selected according to actual needs to achieve the purpose of the scheme of this embodiment. Those of ordinary skill in the art may understand and implement it without creative effort.

[0117] Through the description of the above implementation methods, those skilled in the art can clearly understand that each implementation method can be implemented by means of software plus a necessary general hardware platform, and of course, it can also be implemented by hardware. Based on this understanding, the above technical solution is essentially or the part that contributes to the prior art can be embodied in the form of a software product, and the computer software product can be stored in a computer-readable storage medium, such as ROM / RAM, a disk, an optical disk, etc., including a number of instructions for a computer device (which can be a personal computer, a server, or a network device, etc.) to execute the methods of each embodiment or some parts of the embodiment.

[0118] Although the present invention has been described in detail above by general description and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements can be made to the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all belong to the scope of protection claimed by the present invention.

Claims

1. A non-invasive screening and management method for hyperlipidemia population based on dynamic spectroscopy, characterized in that: The non-invasive screening and management method for hyperlipidemia population based on dynamic spectroscopy specifically includes: Collecting a certain number of human face videos, preprocessing the human face videos to obtain preprocessed data; Obtaining the index information data corresponding to the pre-processed data by dynamic spectroscopy technology; wherein the index information data includes cholesterol data, triglyceride data and low high-density lipoprotein data; Setting a detection threshold to determine whether all the indicator information data exceed the detection threshold. If all the indicator information data exceed the detection threshold, the patient is determined to be a hyperlipidemia patient. If all the indicator information data do not exceed the detection threshold, it is determined that the person does not belong to the hyperlipidemia population; If the indicator information data exceeds one of the detection thresholds, the individual is determined to be a key monitoring target for hyperlipidemia.

2. The non-invasive screening and management method for hyperlipidemia population based on dynamic spectroscopy according to claim 1, characterized in that: The collecting of a certain number of human face videos and preprocessing of the human face videos to obtain preprocessed data includes: The facial video of the human face is collected by a near-infrared dynamic spectrum acquisition device to obtain the spectrum information of the blood components under the skin of the human face; The wave number band information is obtained by screening the wave number band combination with obvious correlation with the components of the compound to be tested in the spectral information through interval partial least squares; The wave number segment information is extracted into wave number point information in combination with the Monte Carlo algorithm.

3. The non-invasive screening and management method for hyperlipidemia population based on dynamic spectroscopy according to claim 1, characterized in that: The indicator information data corresponding to the pre-processed data is obtained by dynamic spectroscopy technology, including: Extracting a plurality of original features based on the preprocessed data; Calculate the correlation coefficients of the original features corresponding to the hyperlipidemia population; The original features whose correlation coefficients exceed the preset standard range are extracted as indicator information data.

4. The non-invasive screening and management method for hyperlipidemia population based on dynamic spectroscopy according to claim 1, characterized in that: The detection threshold of the cholesterol data is 572 mmol / L; The detection threshold of the triglyceride data is 1.70 mmol / L; The detection threshold of the low high-density lipoprotein data is 9.0 mmol / L.

5. The non-invasive screening and management method for hyperlipidemia population based on dynamic spectroscopy according to claim 4, characterized in that: The non-invasive screening management of hyperlipidemia population based on dynamic spectroscopy also includes: When the cholesterol data exceeds 572 mmol / L and the triglyceride data is less than 1.70 mmol / L, it is judged as hypercholesterolemia; When the triglyceride data exceeds 1.70mmo l / L and the cholesterol data is <572mmo l / L, it is considered hypertriglyceridemia. When the cholesterol data exceeds 572 mmol / L and the triglyceride data exceeds 1.70 mmol / L, it is judged as mixed hyperlipidemia; When the low high-density lipoprotein data is less than 9.0 mmol / L, it is diagnosed as low high-density lipoproteinemia.

6. The non-invasive screening and management method for hyperlipidemia population based on dynamic spectroscopy according to claim 5, characterized in that: The non-invasive screening management of hyperlipidemia population based on dynamic spectroscopy also includes: A corresponding treatment plan is determined based on the type of hyperlipidemia, and the treatment plan is sent to a corresponding treatment personnel user terminal.

7. The non-invasive screening and management method for hyperlipidemia population based on dynamic spectroscopy according to claim 1, characterized in that: The non-invasive screening management of hyperlipidemia population based on dynamic spectroscopy also includes: Assign a unique identification code to each screening area; The location of the community hyperlipidemia screening area corresponding to the key hyperlipidemia monitoring object is obtained through the unique identification code.

8. A non-invasive screening and management system for hyperlipidemia population based on dynamic spectroscopy, characterized in that: include: A collection module is used to collect a certain number of facial videos; A preprocessing module, used for preprocessing the face video to obtain preprocessed data; An index extraction module, used for obtaining index information data corresponding to the pre-processed data through dynamic spectroscopy technology; wherein the index information data includes cholesterol data, triglyceride data and low high-density lipoprotein data; A judgment module is used to set a detection threshold to judge whether all the indicator information data exceed the detection threshold. If all the indicator information data exceed the detection threshold, it is judged that the patient belongs to the hyperlipidemia population; If all the indicator information data do not exceed the detection threshold, it is determined that the person does not belong to the hyperlipidemia population; If the indicator information data exceeds one of the detection thresholds, the patient is determined to be a hyperlipidemia patient to be observed.

9. An electronic device comprising a memory, a processor, and a computer program stored in the memory and executable on the processor, characterized in that: When the processor executes the computer program, the steps of the method according to any one of claims 1 to 7 are implemented.

10. A non-transitory computer readable medium having a computer program stored thereon, characterized in that: When the computer program is executed by a processor, the steps of the method according to any one of claims 1 to 7 are implemented.